Answers are grounded in this paper and cite their sources.
Background: Melanoma in children, adolescents, and young adults (CAYA) is critically understudied, leading to suboptimal diagnostic accuracy and treatment approaches. The MELCAYA consortium targets this gap by focusing on the unique epidemiology, progression, and treatment responses of melanoma in CAYA compared to adults. Through integrating European cohorts, employing omics for risk factor identification, developing AI-based diagnostic tools, and validating non-invasive detection methods, MELCAYA aims to enhance melanoma management in this demographic, underscoring the need for tailored research and clinical strategies.
No takes yet. Share an insight, caveat, or question.
Silva-Junior et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: